Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
The URGenT network grant aims to speed up the development and clinical testing of gene-based therapies for ultra-rare neurological or neuromuscular disorders, with the ultimate goal of initiating a clinical trial.
Contact for amount
Closed
Nationwide
Key Dates
Next Deadline
September 11, 2024
Letter of Intent
Application Opens
November 9, 2021
Application Closes
October 11, 2024
Contact Information
Grantor
NIH OER Webmaster
Subscribe to view contact details
Newsletter Required
Categories
Health
